Cancer Risk Evaluation Methods and Trends 1. Auflage - libri usati

EAN (ISBN-13): 9783527327539
ISBN (ISBN-10): 3527327533
Copertina rigida
Anno di pubblicazione: 2011
Editore: Wiley-VCH
348 Pagine
Peso: 0,834 kg
Lingua: eng/Englisch

Libro nella banca dati dal 2009-05-12T14:25:09+02:00 (Rome)
Pagina di dettaglio ultima modifica in 2023-09-06T12:39:37+02:00 (Rome)
ISBN/EAN: 9783527327539

ISBN - Stili di scrittura alternativi:
3-527-32753-3, 978-3-527-32753-9
Stili di scrittura alternativi e concetti di ricerca simili:
Autore del libro : peter schütz, marchant, schutz, gary, wiedemann, burkhard peter, günter burkhard, max delbrück, wiede, gun, march, schut, marcha, wied, peter obe, hölger, wiley vch, teltow
Titolo del libro: risk, eva, cancer

---

Dati dell'editore

Autore: Günter Obe; Burkhard Jandrig; Gary E. Marchant; Holger Schütz; Peter M. Wiedemann
Titolo: Cancer Risk Evaluation - Methods and Trends
Editore: Wiley-Blackwell; Wiley-VCH
348 Pagine
Anno di pubblicazione: 2011-04-20
Stampato / Fatto in
Peso: 0,832 kg
Lingua: Inglese
112,00 € (DE)
Not available (reason unspecified)
170mm x 240mm x 21mm

BB; Hardcover, Softcover / Biologie/Mikrobiologie; Zellbiologie (Zytologie); Verstehen; Biowissenschaften, Biologie; Biowissenschaften; Gesundheitspolitik, Risiken, Sicherheit des Patienten; Gesundheitsrisiko; Health Policy, Health Risk & Patient Safety; Life Sciences; Medical Cell Biology; Medical Oncology; Medical Science; Medizin; Medizinische Onkologie; Medizinische Zellbiologie; Public Health; Risikobewertung; Medizinische Zellbiologie; Gesundheitspolitik, Risiken, Sicherheit des Patienten; Medizinische Onkologie; Vorklinische Medizin, Grundlagenwissenschaften

Preface Introduction MODELS AND APPROACHES Models of cancer development: genetic and environmental influences (Jandrig) Endogenous DNA damage and its relevance for the initiation of carcinogenesis (Epe, Fusser) The IARC Monographs Programme: cancer-hazard identification as a first step in cancer-risk assessment and cancer prevention (Baan, Cogliano) EPIDEMIOLOGICAL RESEARCH The role of epidemiology in cancer risk assessment of non-ionising radiation (Schüz, Berg-Beckhoff, Schlehofer, Blettner) The role of epidemiology in cancer risk assessment of ionizing radiation (Wakeford) ANIMAL STUDIES Animal studies on RF-EMF cancer effects (Dasenbrock, Buschmann) Animal studies in carcinogen identification: The example of power-frequency (50/60 Hz) magnetic fields (McCormick) GENOTOXICITY STUDIES Chromosomal aberrations in human populations and cancer (Obe, Lloyd, Durante) Cytogenetic studies in mammalian somatic cells exposed to radiofrequency radiation: A meta-analysis (Vijayalaxmi , Prihoda) OMICS - A NEW TOOL FOR CANCER RISK ASSESSMENT? Genomics and cancer risk assessment (Schweiger, Timmermann) Transcriptomics and cancer risk assessment (Kemmner) Proteomics and cancer risk assessment (Schramm) CURRENT USE OF OMICS STUDIES FOR CANCER RISK ASSESSMENT Omics in cancer risk assessment: Pathways to disease (Portier, Thomas) What have omics taught us about the health risks associated with exposure to low doses of ionizing radiation? (Morgan, Sowa) Current use of omics studies for cancer risk assessment: Transcriptomics approach in RF-EMF research (Mevissen) Proteomics approach In mobile phone radiation research (Leszczynski) CHALLENGES FOR RISK MANAGEMENT Evaluating the reliability of controversial scientific results (Lerchl) Comparative risk assessment with ionising and non-ionising radiations (Kiefer) Communicating about uncertainties in cancer risk assessment (Wiedemann, Schütz) The Precautionary Principle and radiofrequency exposure from mobile phones (Marchant)